Advancing Clinical Research Innovation | DPHARM 2026 | September 15–16, 2026 | Sheraton Boston Hotel
Geninvo is exhibiting at DPHARM 2026 the industry’s premier conference for disruptive innovations in clinical research taking place September 15–16, 2026 at the Sheraton Boston Hotel, Boston, MA.
Find our team at Booth 116 and discover how GenInvo is transforming the fields like Data Analytics, Biometrics, Regulatory Writing and Data Transparency with cutting-edge technologies.
📅 September 15–16, 2026
📍 Sheraton Boston Hotel, Boston, MA
🏷️ Booth 116
👥 Contacts: Craig | James | Daragh
ABOUT THE EVENT
About DPHARM 2026: Disruptive Innovations to Advance Clinical Research
DPHARM 2026 is the leading conference bringing together senior clinical operations executives, R&D innovators, technology leaders, and patient advocates to explore the future of clinical trials.
Hosted at the Sheraton Boston Hotel, September 15–16, 2026, the event features TED-style talks, fireside chats, quick-fire demos, and the renowned DPHARM Idol Disrupt startup pitch competition all focused on driving efficiencies in clinical trial operations and improving outcomes for patients.
Key themes at DPHARM 2026 include:
- Decentralized and hybrid clinical trials
- AI and data-driven trial design
- Patient-centric research models
- Disruptive technologies accelerating drug development
- Operational excellence in clinical research
WHY VISIT GENINVO AT BOOTH 116?
At DPHARM 2026, the Geninvo team will be showcasing our full suite of AI-powered clinical research and data science solutions purpose-built for pharma sponsors, biotech firms, CROs, and clinical operations teams. Stop by Booth 116 for live demonstrations of five transformative products:
- ✅ Live product demonstrations — see all five GenInvo solutions in action
- ✅ One-on-one consultations with clinical research and data science experts
- ✅ Real-world use cases — how GenInvo is helping teams cut timelines, reduce errors, and stay compliant
- ✅ Exclusive conference offers for DPHARM 2026 attendees
- ✅ Meet Craig, James, and Daragh — our senior team on-site at Booth 116
Whether you are a pharma sponsor, CRO, statistical programmer, medical writer, or data manager — Geninvo has a solution built for your challenge.
GENINVO PRODUCTS AT DPHARM 2026
Discover Geninvo’s AI-Powered Clinical Research Solutions
Geninvo is the go-to partner for the life sciences industry, delivering innovative software solutions and data science services. Our unique combination of deep expertise in life sciences, cutting-edge AI, software development, data engineering, and cloud technologies helps bring life-changing treatments to patients faster. At DPHARM 2026, we are showcasing five products solving the toughest challenges in clinical research today.
CodeMagic™ — AI-Assisted Code Generation for Statistical Programming
Stop writing SDTM, ADaM, and TFL code from scratch. CodeMagic generates it for you.
CodeMagic™ is Geninvo’s AI-assisted code generation platform that automates statistical programming using structured specifications and mock shells. Designed for pharma statisticians and programmers, it generates SDTM, ADaM, and TFL code in open-source languages like R — delivering predictable, controlled, GxP-compliant, audit-ready programs with full documentation.
Key Capabilities:
- Automated ADaM generation with variable-level metadata mapping and derivation logic
- TFL code generation from mock shells and ADaM specifications
- Raw to SDTM conversion using detailed study specifications
- Reusable global standard programs for common derivations
- Seamless integration with client Statistical Computing Environments (SCEs)
- Human-in-the-Loop framework ensuring accuracy, quality, and compliance throughout
Strategic Benefits for Your Team:
- Accelerate time-to-insight and shorten development timelines
- Reduce manual coding errors through intelligent, structured prompts
- Ensure CDISC standards and Good Programming Practices in every output
- Free up programmer capacity for strategic analysis and innovation
- Help SAS programmers transition to R with built-in learning support
- Code is production-ready for validation or QC purposes
On the Roadmap: SAS to R migration, Python/SAS/multi-language support, model-agnostic LLM compatibility.
Datalution™ — Intelligent Synthetic Data Platform for Clinical Trials
Start analytics before the first patient walks in the door.
Datalution™ is Geninvo’s intelligent synthetic data platform that enables clinical trial teams to activate downstream analytics, testing, and validation workflows — all before First-Patient-In. With privacy guaranteed by design (zero patient re-identification risk), Datalution accelerates study configuration and early programming activation without compromising data security.
What Synthetic Data Enables:
- De-risking system validation and programming before trial start
- Validating reconciliation, coding, and data cleaning processes
- Eliminating patient exposure risk entirely
- Testing QTL programs and pre-building TLF shells and analysis programs
- Conducting realistic UAT for EDC, IRT, ePRO, and vendor systems
- Achieving time and cost efficiency across the study lifecycle
Key Highlights:
- Privacy-guaranteed synthetic data infrastructure with zero re-identification risk by design
- Accelerated study configuration and early programming activation
- Unlocks early testing, validation, and system readiness across all trial systems
Shadow™ — Achieve Anonymization with Ease
Anonymize documents, datasets, and DICOM files — fast, accurately, and compliantly.
Shadow™ is Geninvo’s AI-powered anonymization platform covering DICOM, clinical data, and regulatory documents. Using custom NLP and Computer Vision (CV) models to identify Personally Identifiable Information (PII) with precision, Shadow significantly reduces the time and manual effort required for anonymization — while eliminating human error.
Core Capabilities:
- DICOM + Data + Document De-identification in one platform
- PII identification using custom NLP and CV models
- Risk Analysis to assess re-identification risk before and after anonymization
- Anonymization Reports with real-time results
- Data Utility measurement to ensure anonymized data remains analytically useful
Compliance Coverage:
- GDPR, 21 CFR, and HIPAA compliant
- Health Canada and EMA Policy 0070 aligned
- Scalable, customizable Anonymization as a Service model
DocWrightAI™ — AI-Driven Authoring of Clinical & Regulatory Documents
Create your most complex regulatory documents in minutes — without compromising accuracy or compliance.
DocWrightAI™ is Geninvo’s advanced AI writing assistant for collaborative and efficient authoring of clinical and regulatory documents. Trained on official regulatory rules and medical knowledge, it accelerates document timelines from weeks to minutes while keeping human experts in control at every step.
Why It Stands Out:
- Accelerates document authoring timelines from weeks to minutes
- Ensures compliance by design with built-in regulatory intelligence
- AI-assisted, human-approved workflows keep your team in control
- Built-in inconsistency checker catches errors before submission
- Generates documents weeks ahead of schedule
- Collaborative authoring allows multiple team members to work simultaneously
- Customized user prompts generate content tailored to specific study needs
- Human-in-Loop control ensures oversight and validation at every stage
Ideal For: CSRs, protocols, INDs, NDAs, regulatory briefing documents, and all clinical/regulatory writing workflows.
DocQC™ — Automated Medical Writing Review & QC
Cut review cycles. Cut costs. Never compromise on quality.
DocQC™ is Geninvo’s automation tool that streamlines medical writing reviews, dramatically reducing manual effort and time-consuming review cycles. It solves the five biggest pain points in document QC: manual review burden, repetitive tasks causing fatigue, scalability challenges across multiple studies, delayed turnaround slowing regulatory submissions, and high cost per document.
Key Functionalities:
- Document Editing & Review Comments — real-time feedback and document revisions
- Dashboard and Repository — central hub for managing and accessing all documents
- Quality Review — document accuracy and compliance through predefined checklists
- Collaborative Workspace — shared reviewing and editing for enhanced team productivity
- Audit Trails — full change and access tracking to maintain document integrity
- Queue Management System — organizes and prioritizes document review tasks efficiently
Two Flexible Business Models:
- Service Model: Geninvo FSP delivers Clinical & Regulatory Documents directly to clients
- Licensing Model: Clients onboard and operate the DocQC platform independently within their own environment
BOOK A MEETING
Book a Meeting with Geninvo at DPHARM 2026
Don’t leave your DPHARM 2026 schedule to chance. Pre-book a dedicated 15 or 30-minute meeting with our team at Booth 116 and make the most of your time in Boston.
Email us directly: info@geninvo.com
FAQ SECTION
Where is DPHARM 2026 being held?
DPHARM 2026 takes place at the Sheraton Boston Hotel, Boston, Massachusetts, on September 15–16, 2026.
What booth number is Geninvo at DPHARM 2026?
Geninvo is exhibiting at Booth 116 at DPHARM 2026.
How can I meet the Geninvo team at DPHARM 2026?
You can visit us directly at Booth 116, or email at info@geninvo.com.
What does Geninvo do?
Geninvo is a life sciences technology company delivering AI-powered software solutions and data science services for clinical research. Their product portfolio includes CodeMagic™ (AI-assisted statistical programming), Datalution™ (intelligent synthetic data for clinical trials), Shadow™ (data and document anonymization), DocWrightAI™ (AI-driven regulatory document authoring), and DocQC™ (automated medical writing QC). Geninvo helps pharma sponsors, biotech firms, and CROs accelerate drug development and bring life-changing treatments to patients faster.
What products will Geninvo demonstrate at DPHARM 2026?
At Booth 116, the Geninvo team will demonstrate five solutions: CodeMagic™ for AI-assisted SDTM/ADaM/TFL code generation; Datalution™ for synthetic clinical trial data; Shadow™ for DICOM, data, and document anonymization; DocWrightAI™ for AI-powered clinical and regulatory document authoring; and DocQC™ for automated medical writing review and quality control.
What is DPHARM?
DPHARM (Disruptive Innovations to Advance Clinical Research) is an annual conference organized by The Conference Forum (TCF), focused on transformative technologies and innovations modernizing clinical trials.
Is Geninvo exhibiting or sponsoring at DPHARM 2026?
Geninvo is exhibiting at DPHARM 2026 at Booth 116, September 15–16, 2026, in Boston.
